Piedmont Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-148,212
Closed -$4.84M 96
2020
Q1
$4.84M Buy
148,212
+18,139
+14% +$709K 0.19% 121
2019
Q4
$5.88M Buy
130,073
+5,902
+5% +$247K 0.2% 114
2019
Q3
$5.05M Buy
124,171
+1,754
+1% +$74.3K 0.2% 120
2019
Q2
$5.26M Buy
122,417
+23,142
+23% +$890K 0.21% 118
2019
Q1
$3.81M Buy
99,275
+2,045
+2% +$78.1K 0.15% 146
2018
Q4
$3.44M Buy
97,230
+6,483
+7% +$235K 0.16% 134
2018
Q3
$3.49M Buy
90,747
+31,275
+53% +$1.09M 0.15% 142
2018
Q2
$1.95M Sell
59,472
-145,821
-71% -$4.4M 0.09% 221
2018
Q1
$5.61M Sell
205,293
-88,938
-30% -$2.42M 0.15% 172
2017
Q4
$7.29M Sell
294,231
-969
-0.3% -$26.7K 0.15% 179
2017
Q3
$8.61M Buy
295,200
+2,726
+0.9% +$75.3K 0.18% 149
2017
Q2
$8.11M Buy
292,474
+6,495
+2% +$172K 0.18% 149
2017
Q1
$7.11M Buy
285,979
+2,466
+0.9% +$60K 0.15% 175
2016
Q4
$6.13M Buy
283,513
+6,140
+2% +$134K 0.13% 184
2016
Q3
$6.6M Sell
277,373
-28,665
-9% -$684K 0.14% 165
2016
Q2
$7.15M Buy
+306,038
New +$6.62M 0.15% 160
2013
Q3
Sell
-239,800
Closed -$2.22M 324
2013
Q2
$2.22M Buy
+239,800
New +$2.03M 0.1% 124

Other funds holding BSX

Piedmont Investment Advisors's BSX Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 148,212 shares — an estimated $4.84M sold.

Piedmont Investment Advisors first reported a position in BSX in Q2 2013 and held it in 17 quarters. The position peaked at $8.61M in Q3 2017. 840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 148,212 Boston Scientific shares in Q2 2020, an estimated $4.84M.
  • Piedmont Investment Advisors first reported a position in Boston Scientific in Q2 2013 and held it in 17 quarters.
  • Piedmont Investment Advisors's Boston Scientific position peaked at $8.61M in Q3 2017.
  • 840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.